Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 24/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.72B 5.28B 4.77B 8.98B 586B 9.34B 63.82B 25.23B 316B 23.51B 23.02B 998B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.55B 5.14B 4.63B 8.73B 569B 9.07B 62.03B 24.52B 307B 22.85B 22.37B 970B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 6 months | +2.17% | ||
| Current year | +61.94% |
| Current year | 21.5 | 40.56 | |
| 1 year | 21.5 | 40.56 | |
| 3 years | 5.58 | 40.56 | |
| 5 years | 2.88 | 40.56 | |
| 10 years | 2.88 | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/03/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.80% | -.--% | +42.81% | +475.28% | 6.27B | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 65.45B | ||
| +0.59% | -1.83% | +8.98% | +90.01% | 58.93B | ||
| +0.54% | +0.45% | +25.96% | +87.77% | 55.21B | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 46.1B | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 42.49B | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 35.56B | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 34.57B | ||
| -0.17% | -1.83% | +82.46% | +57.69% | 32.46B | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 26.28B | ||
| Average | -0.79% | -2.87% | +35.03% | +199.47% | 40B | |
| Weighted average by Cap. | -0.81% | -3.21% | +34.31% | +148.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.68 12.65 11.41 21.5 1.4K 22.35 152.76 60.39 756.58 56.27 55.1 2.39K |
| Net income | -236M -215M -199M -179M -338M -22.03B -351M -2.4B -949M -11.89B -884M -866M -37.55B | -198M -180M -167M -150M -283M -18.46B -294M -2.01B -795M -9.96B -741M -726M -31.46B |
| Net Debt | -364M -332M -307M -277M -522M -34.05B -543M -3.71B -1.47B -18.38B -1.37B -1.34B -58.03B | -176M -161M -149M -134M -253M -16.47B -262M -1.79B -709M -8.89B -661M -647M -28.06B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
















